Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06315179 · ClinicalTrials.gov registry record
Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)
A clinical trial of Ulcerative Colitis and Crohn Disease, sponsored by Seattle Children's Hospital.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT06315179: Recruiting study of Ulcerative Colitis and Crohn Disease, sponsored by Seattle Children's Hospital.
NCT06315179 is a study of Ulcerative Colitis and Crohn Disease that is actively recruiting participants, run by Seattle Children's Hospital. The registered enrollment target is 200 participants, below the 2,056-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06315179, a study of Ulcerative Colitis and Crohn Disease, is actively recruiting participants, sponsored by Seattle Children's Hospital.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective observational study collecting long-term clinical data and samples for research in pediatric inflammatory bowel disease (IBD) patients with gut inflammation and a control cohort of pediatric patients with disorders of the brain-gut interactions (DBGI) with no detectable gut inflammation.
Primary Outcome
Collection of blood and stool samples at baseline month 1, month 2, month 3, month 6, month 12, month 24, and month 36. Tissue will be collected at baseline and at any follow-up endoscopy or surgical intervention.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Esophagogastroduodenoscopy (EGD) with biopsy
- DIAGNOSTIC_TEST Colonoscopy w/ biopsy
Study Locations (1)
Washington
- Seattle Children's Hospital - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-05-10 |
| Est. Completion | 2030-01 |
What NCT06315179 shows while recruiting
NCT06315179 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 2,056-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (90% lower).
The record links to 10 conditions, with Ulcerative Colitis appearing as the primary indexed condition, and to 2 interventions - of which Esophagogastroduodenoscopy (EGD) with biopsy is the first listed.
NCT06315179 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT06315179 about?
NCT06315179 is a clinical study titled "Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)". This is a prospective observational study collecting long-term clinical data and samples for research in pediatric inflammatory bowel disease (IBD) patients with gut inflammation and a control cohort of pediatric patients with disorders of the brain-gut interactions (DBGI) with no detectable gut inf...
What is the current status of trial NCT06315179?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2024-05-10. Estimated completion is 2030-01.
What conditions does trial NCT06315179 study?
This clinical trial studies the following conditions: Ulcerative Colitis, Crohn Disease, Inflammatory Bowel Diseases, Indeterminate Colitis, Esophageal Diseases.
What interventions are being tested in trial NCT06315179?
The interventions under investigation include: Esophagogastroduodenoscopy (EGD) with biopsy (DIAGNOSTIC_TEST), Colonoscopy w/ biopsy (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06315179?
This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06315179 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ulcerative Colitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06315179's enrollment target sits among peer trials
200 43rd of 122 higher than 79 of 122 other Ulcerative Colitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ulcerative Colitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
RECRUITING · Phase 2
-
Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
RECRUITING
-
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
RECRUITING · NA
-
A Study of Endoscopic Sleeve Gastroplasty for Obesity in Ulcerative Colitis
RECRUITING · NA
-
Registry and Biorepository for IBD in Central Texas
RECRUITING
-
Nicotinamide Riboside in Ulcerative Colitis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI